Ranbaxy Laboratories is reportedly looking to acquire US Food & Drug Administration (US FDA)-approved manufacturing facility in India to secure its future launches and shift some of its blockbuster drug filings in an attempt to reduce risks arising out of issues with its Mohali plant.
http://www.epicresearch.co/
0731-664-2300
http://www.epicresearch.co/
0731-664-2300
0 comments:
Post a Comment